Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$221.92 - $245.94 $8.65 Million - $9.58 Million
-38,958 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$215.77 - $276.76 $1.24 Million - $1.58 Million
-5,724 Reduced 12.81%
38,958 $9.07 Million
Q2 2020

Aug 05, 2020

SELL
$219.9 - $263.41 $586,693 - $702,777
-2,668 Reduced 5.63%
44,682 $10.7 Million
Q1 2020

May 06, 2020

SELL
$195.69 - $279.01 $10.5 Million - $14.9 Million
-53,464 Reduced 53.03%
47,350 $10.9 Million
Q4 2019

Feb 12, 2020

SELL
$236.45 - $266.82 $3.06 Million - $3.45 Million
-12,926 Reduced 11.36%
100,814 $27.4 Million
Q3 2019

Nov 15, 2019

BUY
$230.58 - $256.08 $299,754 - $332,904
1,300 Added 1.16%
113,740 $28.8 Million
Q2 2019

Aug 12, 2019

BUY
$217.4 - $246.08 $167,832 - $189,973
772 Added 0.69%
112,440 $28.3 Million
Q1 2019

May 06, 2019

BUY
$206.05 - $248.17 $351,315 - $423,129
1,705 Added 1.55%
111,668 $27.9 Million
Q4 2018

Feb 11, 2019

BUY
$204.73 - $257.93 $268,196 - $337,888
1,310 Added 1.21%
109,963 $24.8 Million
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $7,225 - $7,936
31 Added 0.03%
108,653 $28.4 Million
Q2 2018

Aug 10, 2018

SELL
$208.1 - $233.85 $1.01 Million - $1.14 Million
-4,876 Reduced 4.3%
108,622 $26 Million
Q1 2018

May 11, 2018

SELL
$205.46 - $240.27 $75,198 - $87,938
-366 Reduced 0.32%
113,498 $24.6 Million
Q4 2017

Feb 07, 2018

BUY
$189.0 - $222.64 $1.33 Million - $1.57 Million
7,052 Added 6.6%
113,864 $24.4 Million
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $20 Million - $21.2 Million
106,812
106,812 $20.9 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Chilton Investment CO Inc. Portfolio

Follow Chilton Investment CO Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Investment CO Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chilton Investment CO Inc. with notifications on news.